Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Vatter

Showing results (301-310 of 311) with videos related to

Pageof 32
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 27, 2026
Conducting a randomized controlled clinical trial on palliative care in patients with glioblastoma - what are the challenges?Melanie Joshi, Charlotte Nettekoven, Sophia Kochs, et al.
Neurosurgery|January 26, 2023
Reappraisal of Intracerebral Hemorrhages and Intracerebral Hemorrhage Grading Scale Score in Surgically and Medically Managed Cerebellar Intracerebral HemorrhageSae-Yeon Won, Johannes Walter, Silvia Hernandez-Duran, et al.
Brain & Spine|January 8, 2026
Size of decompressive craniectomy as prognostic factor in space-occupying ischemic cerebellar stroke -a multicentric retrospective studySilvia Hernández-Durán, Johannes Walter, Daniel Dubinski, et al.
Epilepsia Open|April 1, 2025
A public benchmark for human performance in the detection of focal cortical dysplasiaLennart Walger, Matthias H Schmitz, Tobias Bauer, et al.
Brain : a Journal of Neurology|April 12, 2022
Spreading depolarizations in ischaemia after subarachnoid haemorrhage, a diagnostic phase III studyJens P Dreier, Maren K L Winkler, Sebastian Major, et al.
Investigative Radiology|October 22, 2024
A Quantitative Comparison Between Human and Artificial Intelligence in the Detection of Focal Cortical DysplasiaLennart Walger, Tobias Bauer, David Kügler, et al.
Lancet (London, England)|February 21, 2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialUlrich Herrlinger, Theophilos Tzaridis, Frederic Mack, et al.
Epilepsia|February 24, 2024
Defining benchmark outcomes for mesial temporal lobe epilepsy surgery: A global multicenter analysis of 1119 casesRichard Drexler, Franz L Ricklefs, Sharona Ben-Haim, et al.
Journal of Neurosurgery|January 23, 2026
Safety in epilepsy surgery: a multicenter analysis of surgery-related complications and seizure outcome in 1167 cases of mesial temporal lobe epilepsyTobias Pantel, Richard Drexler, Sharona Ben-Haim, et al.
BMC Cancer|February 20, 2025
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastomaMatthias Schneider, Anna-Laura Potthoff, Yahya Ahmadipour, et al.
Pageof 32

Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 27, 2026
Conducting a randomized controlled clinical trial on palliative care in patients with glioblastoma - what are the challenges?Melanie Joshi, Charlotte Nettekoven, Sophia Kochs, et al.
Neurosurgery|January 26, 2023
Reappraisal of Intracerebral Hemorrhages and Intracerebral Hemorrhage Grading Scale Score in Surgically and Medically Managed Cerebellar Intracerebral HemorrhageSae-Yeon Won, Johannes Walter, Silvia Hernandez-Duran, et al.
Brain & Spine|January 8, 2026
Size of decompressive craniectomy as prognostic factor in space-occupying ischemic cerebellar stroke -a multicentric retrospective studySilvia Hernández-Durán, Johannes Walter, Daniel Dubinski, et al.
Epilepsia Open|April 1, 2025
A public benchmark for human performance in the detection of focal cortical dysplasiaLennart Walger, Matthias H Schmitz, Tobias Bauer, et al.
Brain : a Journal of Neurology|April 12, 2022
Spreading depolarizations in ischaemia after subarachnoid haemorrhage, a diagnostic phase III studyJens P Dreier, Maren K L Winkler, Sebastian Major, et al.
Investigative Radiology|October 22, 2024
A Quantitative Comparison Between Human and Artificial Intelligence in the Detection of Focal Cortical DysplasiaLennart Walger, Tobias Bauer, David Kügler, et al.
Lancet (London, England)|February 21, 2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialUlrich Herrlinger, Theophilos Tzaridis, Frederic Mack, et al.
Epilepsia|February 24, 2024
Defining benchmark outcomes for mesial temporal lobe epilepsy surgery: A global multicenter analysis of 1119 casesRichard Drexler, Franz L Ricklefs, Sharona Ben-Haim, et al.
Journal of Neurosurgery|January 23, 2026
Safety in epilepsy surgery: a multicenter analysis of surgery-related complications and seizure outcome in 1167 cases of mesial temporal lobe epilepsyTobias Pantel, Richard Drexler, Sharona Ben-Haim, et al.
BMC Cancer|February 20, 2025
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastomaMatthias Schneider, Anna-Laura Potthoff, Yahya Ahmadipour, et al.
Pageof 32